AbbVie Free Cash Flow 2010-2024 | ABBV

AbbVie free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.

  • AbbVie annual free cash flow for 2023 was $22.062B, a 9.02% decline from 2022.
  • AbbVie annual free cash flow for 2022 was $24.248B, a 10.27% increase from 2021.
  • AbbVie annual free cash flow for 2021 was $21.99B, a 30.97% increase from 2020.

AbbVie Free Cash Flow 2010-2024 | ABBV

  • AbbVie annual free cash flow for 2023 was $22.062B, a 9.02% decline from 2022.
  • AbbVie annual free cash flow for 2022 was $24.248B, a 10.27% increase from 2021.
  • AbbVie annual free cash flow for 2021 was $21.99B, a 30.97% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$755.3B
Novo Nordisk (NVO)$392.1B
Johnson & Johnson (JNJ)$351.2B
Merck (MRK)$251.6B
AstraZeneca (AZN)$205.6B
Novartis AG (NVS)$201B
Pfizer (PFE)$151.5B
Sanofi (SNY)$122.6B
Bayer (BAYRY)$19.1B
Innoviva (INVA)$1.1B